Ledger.Open graph →
SEC Form D · filed December 10, 2014

FIBROGEN INC

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

James A. Schoeneck · San Francisco, CADirectorFrank H. Valone · San Francisco, CAExecThomas F. Kearns · San Francisco, CADirectorK. Peony H. Yu · San Francisco, CAExecJorma P. Routti · San Francisco, CADirectorMiguel F. Madero · San Francisco, CADirectorRory B. Riggs · San Francisco, CADirectorToshinari N. Tamura · San Francisco, CADirectorKalevi F. Kurkijarvi · San Francisco, CADirectorJulian N. Stern · San Francisco, CADirectorThomas B. Neff · San Francisco, CAExec · DirectorPat B. Cotroneo · San Francisco, CAExecRoberto P. Rosenkranz · San Francisco, CADirectorKalevi F. Kurkijarvi · San Francisco, CADirectorJulian N. Stern · San Francisco, CADirectorThomas B. Neff · New Haven, CTExec · DirectorJames A. Schoeneck · San Diego, CADirectorPat B. Cotroneo · San Francisco, CAExecFrank H. Valone · San Francisco, CAExecThomas F. Kearns · San Francisco, CADirectorK. Peony H. Yu · San Francisco, CAExecJorma P. Routti · San Francisco, CADirectorMiguel F. Madero · San Francisco, CADirectorRory B. Riggs · San Francisco, CADirectorToshinari N. Tamura · San Francisco, CADirectorRoberto P. Rosenkranz · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗